Condor Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-894
Closed -$235K 203
2022
Q4
$235K Sell
894
-79
-8% -$21.2K 0.03% 190
2022
Q3
$219K Buy
973
+80
+9% +$19.4K 0.03% 191
2022
Q2
$217K Sell
893
-50
-5% -$12.3K 0.03% 185
2022
Q1
$228K Hold
943
0.03% 192
2021
Q4
$212K Buy
+943
New +$199K 0.02% 188
2021
Q2
Sell
-809
Closed -$201K 319
2021
Q1
$201K Buy
+809
New +$193K 0.02% 191
2020
Q4
Sell
-810
Closed -$206K 192
2020
Q3
$206K Sell
810
-70
-8% -$17.3K 0.03% 171
2020
Q2
$208K Buy
+880
New +$201K 0.03% 171

Other funds holding AMGN

Condor Capital Management's AMGN Position: Q1 2023 in Review

Condor Capital Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 894 shares — an estimated $235K sold.

Condor Capital Management first reported a position in AMGN in Q2 2020 and held it in 8 quarters. The position peaked at $235K in Q4 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Condor Capital Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Condor Capital Management sold 894 Amgen shares in Q1 2023, an estimated $235K.
  • Condor Capital Management first reported a position in Amgen in Q2 2020 and held it in 8 quarters.
  • Condor Capital Management's Amgen position peaked at $235K in Q4 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Condor Capital Management's 13F filing for Q1 2023, filed 10 May 2023.